v3.26.1
Deferred Revenue (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Revenues [Abstract]    
Schedule of Deferred Revenue and Entrance Fee Receivables

The following table summarizes the Company’s deferred revenue (in thousands):

March 31,

December 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

Non-refundable entrance fees

$

677,284

$

669,528

Other deferred revenue

 

2,771

 

3,479

Deferred revenue

$

680,055

$

673,007

The opening and closing balances of non-refundable entrance fees were as follows (in thousands):

Closing balance - December 31, 2024

  ​ ​ ​

$

615,723

Additions(1)

 

152,717

Amortization(2)

 

(98,912)

Closing balance - December 31, 2025

$

669,528

Additions

 

34,959

Amortization(2)

 

(27,203)

Closing balance - March 31, 2026

$

677,284

(1)During the three months ended March 31, 2025, the Company collected non-refundable entrance fees of $29 million.
(2)Amortization of non-refundable entrance fees is included within resident fees and services on the Combined and Consolidated Statements of Operations. During the three months ended March 31, 2025, the Company recognized amortization of $24 million.
The following table summarizes the Company’s entrance fee receivables, which are recognized in other assets on the Combined and Consolidated Balance Sheets (in thousands):

Closing balance - December 31, 2024

  ​ ​ ​

$

61,273

Current year deferrals provided

 

99,960

Receipts applied to entrance fee commitments

 

(87,857)

Closing balance - December 31, 2025

$

73,376

Current year deferrals provided

 

25,813

Receipts applied to entrance fee commitments

 

(25,290)

Closing balance - March 31, 2026

$

73,899

The following table summarizes the Company’s deferred revenue (in thousands):

December 31,

  ​ ​ ​

2025

  ​ ​ ​

2024

Non-refundable entrance fees

$

669,528

$

615,723

Other deferred revenue

 

3,479

 

1,031

Deferred revenue

$

673,007

$

616,754